Skip to main content
. 2021 Jan-Mar;25(1):e2020.00116. doi: 10.4293/JSLS.2020.00116

Table 1.

Patients Characteristics and Surgical Outcomes

All Mild (GI) Severe (GII/GIII) P value (Mild versus Severe)
Number (n) 370 282 88
Gender (Male/Female) 189/181 145/137 44/44 0.8163
Age (years) 63.0 ± 15.0a 61.6 ± 14.1 68.1 ± 14.9 0.0002
BMI (kg/m2) 24.4 ± 3.6 24.5 ± 3.6 24.1 ± 3.6 0.3571
T-Bil (mg/dL) 1.07 ± 0.92 1.0 ± 0.9 1.3 ± 0.9 0.0106
D-Bil (mg/dL) 0.5 ± 0.7 0.5 ± 0.7 0.6 ± 0.3 0.0253
AST (IU/L) 71.0 ± 170.0 54.4 ± 105.9 124.3 ± 288.4 0.0018
ALT (IU/L) 82.0 ± 170.0 70.7 ± 112.9 118.2 ± 282.0 0.0323
LDH (IU/L) 222.0 ± 114.0 206.4 ± 73.1 271.3 ± 185.1 < 0.0001
ALP (IU/L) 322.0 ± 206.0 303.8 ± 192.0 379.1 ± 237.6 0.0045
GGT (IU/L) 154.0 ± 217.0 141.6 ± 184.5 193.4 ± 295.7 0.0617
Alb (g/dL) 4.2 ± 1.3 4.3 ± 1.4 3.8 ± 0.8 < 0.0001
BUN (mg/dL) 15.2 ± 11.0 14.6 ± 11.4 16.9 ± 9.8 0.1147
Cre (mg/dL) 0.9 ± 1.2 0.8 ± 1.1 1.0 ± 1.4 0.2685
Amy (IU/L) 106.0 ± 173.0 97.7 ± 126.8 127.8 ± 257.0 0.2681
CRP (mg/dL) 4.1 ± 7.9 1.9 ± 4.9 9.1 ± 10.6 < 0.0001
WBC (/μL) 7389.0 ± 4177.0 6327.5 ± 2527.8 10792.3 ± 6165.0 < 0.0001
Plt (104/μL) 23.6 ± 7.5 24.0 ± 6.8 22.6 ± 9.4 0.1333
PT-INR (no unit) 1.04 ± 0.6 0.98 ± 0.08 1.21 ± 1.1 < 0.0001
PaO2 (mmHg) 82.4 ± 16.6 83.9 ± 13.5 78.6 ± 22.42 0.0305
CCI (points) 3.6 ± 1.9 3.4 ± 1.8 4.2 ± 2.0 0.0309
ASA-PS (n, %)
 I 137, 37.0 120, 42.6 17, 19.3 < 0.0001
 II 196, 53.0 143, 50.7 53, 60.2
 III 37, 10.0 19, 6.7 18, 20.5
Operating time (min) 62.3 ± 23.7 60.2 ± 22.3 68.8 ± 26.8 0.0037
Blood loss (mL) 24.4 ± 68.6 13.3 ± 40.1 59.9 ± 114.5 < 0.0001
Conversion to open (n) 0 0 0 1.0000
Conversion to bail-out procedure (n) 7 7 0 0.3064
Comprehensive complication index 0.7 ± 0.9 0.6 ± 3.9 3.3 ± 9.3 0.0006
Postoperative complication (n, %) 22, 5.9 13, 4.6 9, 10.2 0.0002
Mortality (n) 0 0 0 1.0000
Postoperative hospital stay (days) 3.6 ± 3.0 3.4 ± 1.7 4.4 ± 5.2 0.0035
a

Continuous data were expressed as mean ± standard deviation.